Skip to main navigation
Skip to search
Skip to main content
University of Arizona Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Search by expertise, name or affiliation
Stroke: Development, prevention and treatment with peptidase inhibitors
K. S. Mark,
T. P. Davis
Pharmacology
BIO5, Institute of
Physiological Sciences - GIDP
Neuroscience - GIDP
Pharmacology and Toxicology
Research output
:
Contribution to journal
›
Review article
›
peer-review
42
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Stroke: Development, prevention and treatment with peptidase inhibitors'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Angiotensin-converting Enzyme Inhibitor (ACEi)
100%
Peptidase Inhibitors
100%
United States
50%
Neurologic Disorders
50%
Hypertension
50%
Antihypertensive Drugs
50%
Cellular Mechanisms
50%
On-state Current
50%
Major Risk Factors
50%
Stroke Mortality
50%
Long-term Disability
50%
Chronic Hypertension
50%
Microvascular Alterations
50%
Pharmacology, Toxicology and Pharmaceutical Science
Dipeptidyl Carboxypeptidase Inhibitor
100%
Peptidase
100%
Disease
50%
Neurologic Disease
50%
Antihypertensive Agent
50%
Neuroscience
Peptidase
100%
ACE Inhibitor
100%
Antihypertensive Agent
50%